← Back to headlines
Nyxoah Reports Positive Safety and Efficacy Results from ACCCESS U.S. Study
The company announced that its pivotal ACCCESS clinical trial met primary safety and efficacy endpoints in patients with complete concentric collapse.
2 Sept, 20:05 — 2 Sept, 20:05
Related Stories
UNICEF Report Reveals 20 Million Children Face Annual Online Sexual Exploitation
33m ago
Genetically Modified Pig Kidney Sustains Patient for Record Nine Months
1h ago
Pentagon Temporarily Rescinds Testosterone Screening Guidance for Troops
6h ago
RFK Jr. Allegedly Requested Removal of Measles Deaths From CDC Tally
7h ago